Andercore | $40,000,000 | (Feb 11, 2026)
Garner Health | $118,000,000 | (Feb 11, 2026)
NATILUS | $28,000,000 | (Feb 11, 2026)
Certified by Founder
Lodge
Clarametyx Biosciences
start up
United States
- Columbus, Ohio
- 08/01/2024
- Series A
- $33,000,000
Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.
- Industry Biotechnology Research
- Website https://clarametyx.com/
- LinkedIn https://www.linkedin.com/company/clarametyx-biosciences/about/
Related People
David V. RichardsFounder
United States -
Columbus, Ohio
Life sciences executive and entrepreneur with a passion for building transformative science into compelling companies. Focus on high patient need categories that hold the potential for broad impact on national and global health, with a personal interest in infectious disease, neurocognitive and genetic disorders.
tem | $75,000,000 | (Feb 11, 2026)
Entire | $60,000,000 | (Feb 11, 2026)
Lema AI | $24,000,000 | (Feb 11, 2026)
ZeroDrift | $2,000,000 | (Feb 11, 2026)
Force Equals | $2,200,000 | (Feb 11, 2026)
Bretton AI | $75,000,000 | (Feb 11, 2026)
Pelgo | $5,500,000 | (Feb 11, 2026)
Newo.ai | $25,000,000 | (Feb 11, 2026)
Equal Parts | $23,000,000 | (Feb 11, 2026)